In a 52-year-old asymptomatic man with fasting plasma glucose 132 mg/dL, hemoglobin A1C 6.7%, and repeat fasting plasma glucose 128 mg/dL, which laboratory result best establishes the diagnosis of diabetes mellitus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Fasting Plasma Glucose ≥126 mg/dL Best Establishes the Diagnosis

In this asymptomatic patient, a fasting plasma glucose ≥126 mg/dL on two separate occasions (which he already has with values of 132 and 128 mg/dL) establishes the diagnosis of diabetes mellitus. His current laboratory results already meet diagnostic criteria for diabetes.

Why This Patient Already Has Diabetes

This patient's presentation demonstrates a critical teaching point: he already meets diagnostic criteria for diabetes based on his two fasting plasma glucose values of 132 mg/dL and 128 mg/dL, both exceeding the 126 mg/dL threshold 1, 2, 1.

According to current guidelines 1, 2, 1:

  • Fasting plasma glucose ≥126 mg/dL (7.0 mmol/L) is diagnostic of diabetes
  • Hemoglobin A1C ≥6.5% (48 mmol/mol) is diagnostic of diabetes
  • In asymptomatic patients, two abnormal test results are required for diagnosis

Analysis of This Patient's Results

Current laboratory values:

  • FPG #1: 132 mg/dL (above threshold)
  • FPG #2: 128 mg/dL (above threshold)
  • HbA1C: 6.7% (above threshold)

This patient has three separate abnormal values, any two of which confirm diabetes. The diagnosis is already established 2, 1.

Evaluating the Answer Choices

Looking at the provided options (which appear to contain typographical errors):

  • "Fasting plasma glucose ≥126 mg/dL" is the correct diagnostic criterion and what this patient already meets
  • "Hemoglobin A1C ≥6.0%" would also establish diagnosis (his is 6.7%, exceeding the 6.5% threshold)
  • "Random plasma glucose ≥200 mg/dL in the absence of symptoms" would require symptoms to avoid the need for confirmatory testing 1

The Diagnostic Algorithm

For asymptomatic patients 1, 2, 1:

  1. Any single test above threshold requires confirmation:

    • Repeat the same test on a different day, OR
    • Perform a different test (e.g., if FPG was first, use HbA1C for confirmation), OR
    • Measure two different tests from the same sample
  2. Two abnormal results confirm diabetes:

    • Same test repeated (e.g., two FPG ≥126 mg/dL)
    • Two different tests both elevated (e.g., FPG ≥126 mg/dL AND HbA1C ≥6.5%)
  3. Exception: Symptomatic patients with random glucose ≥200 mg/dL (11.1 mmol/L) do not require repeat testing 1

Important Clinical Caveats

When FPG is more reliable than HbA1C 3, 4:

  • Conditions with altered red blood cell turnover (sickle cell disease, pregnancy second/third trimester, recent blood loss/transfusion, hemodialysis, erythropoietin therapy)
  • Hemoglobin variants that interfere with assay
  • Glucose-6-phosphate dehydrogenase deficiency
  • Iron-deficiency anemia

Preanalytical considerations 4:

  • Plasma glucose samples must be centrifuged and separated immediately after collection
  • Samples left at room temperature will show falsely low glucose values
  • This is why repeat testing sometimes falls below diagnostic thresholds

Comparative Diagnostic Performance

Recent evidence suggests FPG may have superior diagnostic accuracy compared to HbA1C 5. A 2026 systematic review found FPG demonstrated higher overall diagnostic performance with an optimal cutoff of 6.3 mmol/L (113 mg/dL), yielding 73% sensitivity and 91% specificity, compared to HbA1C's 62% sensitivity and 92% specificity at the 6.5% threshold 5.

However, both tests remain guideline-endorsed and either can establish the diagnosis when properly confirmed 1, 2, 1.

Bottom Line for This Case

This patient's diagnosis is already confirmed. He has two separate fasting plasma glucose measurements both ≥126 mg/dL (132 and 128 mg/dL), which definitively establishes diabetes mellitus 1, 2, 1. His HbA1C of 6.7% provides additional confirmation. No further testing is needed to make the diagnosis—the focus should shift to classification of diabetes type, assessment for complications, and initiation of appropriate management 2, 6.

Related Questions

What is the next best step in management for a 64-year-old female with diabetes, hypertension, hyperlipidemia, and intellectual disability who is not on any medications and has an elevated hemoglobin A1c?
What preconception management should I, as a diabetologist, provide for a 30-year-old woman with type 2 diabetes mellitus for 3 years, hemoglobin A1c 6.4%, currently taking sitagliptin, metformin, and glimepiride, with a body mass index of 24, who wishes to become pregnant in the next 3–4 months?
For a 32‑year‑old obese male with a 10‑year history of diabetes, BMI ~35 kg/m², initial HbA1c 13.8 % (now 8.4 %), microalbuminuria, positive IA‑2 autoantibody, preserved C‑peptide, and current therapy of twice‑daily insulin (Ryzodeg), metformin (Istamet), pioglitazone (Lipaglyn), and semaglutide, should I maintain this regimen, cautiously reduce insulin dose, add an SGLT2 inhibitor, or make other therapeutic adjustments?
How should a 32-year-old male with untreated type 2 diabetes mellitus who has flu-like symptoms and has been unable to retain oral intake for several days be managed?
What is the recommended treatment for a 28-year-old patient with newly diagnosed type 2 diabetes mellitus?
What is the recommended management for distal triceps tendinosis with enthesopathic changes at the olecranon insertion?
Is hydroxyzine included in the Beers Criteria list of potentially inappropriate medications for older adults?
Can montelukast be used for asthma and allergic rhinitis, and are there any drug interactions with hydroxyzine?
At what hemoglobin level should phlebotomy be initiated and what target hemoglobin range should be maintained in patients with autosomal dominant polycystic kidney disease (ADPKD)?
A patient on testosterone therapy was discontinued because the prostate-specific antigen (PSA) was 30 ng/mL; if the subsequent PSA is 15 ng/mL, what are the recommended next steps?
Is a marker‑ball (fiducial) radiograph used for Mako robotic‑assisted total hip arthroplasty or for conventional total hip replacement?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.